# ESX1

## Overview
ESX1 is a gene that encodes the ESX homeobox 1 protein, a transcription factor involved in the regulation of cell proliferation and differentiation, particularly in the context of spermatogenesis and placental development. The ESX1 protein is characterized by a homeodomain, which is a helix-turn-helix DNA binding domain typical of homeobox genes, and a proline-rich region that facilitates interactions with other proteins (Yan2000A; Wang2007Rapid). This protein is primarily localized in the cytoplasm of extraembryonic tissues, such as the developing placenta, and plays a crucial role in linking cytoplasmic signaling events with nuclear transcriptional regulation (Yan2000A). The ESX1 gene is implicated in reproductive health, with mutations and altered expression associated with conditions such as non-obstructive azoospermia and fetal growth restriction (Murthi2006Homeobox; Ma2021Association).

## Structure
The ESX1 protein, encoded by the ESX1 gene, exhibits a complex modular organization with distinct structural features. It contains a homeodomain, a 60-amino-acid helix-turn-helix DNA binding domain, which is a characteristic feature of homeobox genes (Wang2007Rapid). This homeodomain spans amino acids 183 to 248 and is part of the paired-like class, which is atypical for standard homeodomains (Yan2000A). The protein also includes a proline-rich region that contains an SH3 binding motif, suggesting potential interactions with other proteins (Yan2000A). 

A unique feature of the ESX1 protein is the PF/PN motif, consisting of prolines alternating with phenylalanines or asparagines, which inhibits nuclear localization and DNA binding activity (Yan2000A). The protein is primarily localized in the cytoplasm, particularly in extraembryonic tissues like the developing placenta (Yan2000A). 

The ESX1 gene produces two transcript variants, A and B, which differ at their 5' ends, leading to proteins with different N-terminal regions (Yan2000A). The N-terminal extension contains potential phosphorylation sites, indicating post-translational modifications (Yan2000A).

## Function
The ESX1 gene encodes a transcription factor that plays a crucial role in regulating the balance between cell proliferation and differentiation in spermatocytes. In healthy human cells, ESX1 is primarily expressed in the nucleus of spermatogonia within the testis, where it influences the transition of spermatogonia to later stages of spermatogenesis (Malcher2023ESX1). The gene functions by promoting cell differentiation through the upregulation of differentiation-related genes and the downregulation of proliferation-related genes, such as NANOG, which is essential for maintaining pluripotency (Malcher2023ESX1).

ESX1 is also involved in the regulation of the cell cycle during spermatogenesis. The protein is proteolytically processed into two fragments: a 45-kDa N-terminal fragment that acts as a transcriptional repressor in the nucleus, and a 20-kDa C-terminal fragment found in the cytoplasm that inhibits the degradation of cyclins A and B1, leading to cell-cycle arrest (Wang2007Rapid). This regulatory mechanism suggests that ESX1 plays a significant role in ensuring proper cell division and differentiation in male germ cells, contributing to normal spermatogenesis and fertility (Wang2007Rapid).

## Clinical Significance
Mutations and altered expression of the ESX1 gene have been implicated in several reproductive disorders, particularly non-obstructive azoospermia (NOA) in males. NOA is a severe form of male infertility characterized by the absence of sperm in the ejaculate due to impaired spermatogenesis. Studies have identified rare ESX1 gene variants, including the p.P365R mutation, which is considered high-risk for NOA. This mutation affects the polyubiquitination of cyclin A, crucial for cell cycle control during germ cell production, potentially leading to defects in spermatogonia proliferation and spermatogenesis (Malcher2023ESX1; Ma2021Association).

Alterations in ESX1 expression levels have also been associated with fetal growth restriction (FGR), a condition where the fetus does not reach its full growth potential in utero. Decreased ESX1 expression is linked to human pre-term idiopathic FGR, suggesting its role in placental function and fetal growth (Murthi2006Homeobox; Wang2007Rapid).

The ESX1 gene's rapid evolution in humans and its role in regulating cell cycle progression during spermatogenesis highlight its clinical significance in reproductive health and development (Wang2007Rapid).

## Interactions
The ESX1 protein is involved in several interactions with other proteins and nucleic acids, which are crucial for its function. It contains a proline-rich region that facilitates binding to SH3 and WW domains. Specifically, the ESX1 peptide E#1 binds strongly to the c-abl SH3 domain and weakly to the c-fyn SH3 domain, but not to the N-src SH3 domain. Full-length and truncated ESX1 proteins with the proline-rich region also interact with the c-abl and c-fyn SH3 domains, while those lacking this region do not. This proline-rich region also interacts with WW domains, particularly with the FBP30 WW domain and to a lesser extent with the FBP11 WW domain (Yan2000A).

The ESX1 protein's DNA binding activity is weak and specific, with a preference for site 6, which is distinct from other paired-like homeoproteins. It binds DNA as a monomer, unlike other paired-like homeodomains that typically bind as dimers. The N-terminal regions of ESX1 contribute to its DNA binding specificity and affinity (Yan2000A). These interactions suggest that ESX1 may play a role in linking cytoplasmic signaling events with nuclear transcriptional regulation, which is essential for its function in placental development (Yan2000A).


## References


[1. (Wang2007Rapid) Xiaoxia Wang and Jianzhi Zhang. Rapid evolution of primate esx1 , an x-linked placenta- and testis-expressed homeobox gene. Human Molecular Genetics, 16(17):2053–2060, June 2007. URL: http://dx.doi.org/10.1093/hmg/ddm153, doi:10.1093/hmg/ddm153. This article has 16 citations and is from a domain leading peer-reviewed journal.](https://doi.org/10.1093/hmg/ddm153)

[2. (Malcher2023ESX1) Agnieszka Malcher, Zuzanna Graczyk, Hermann Bauer, Tomasz Stokowy, Andrea Berman, Mikołaj Smolibowski, Dominika Blaszczyk, Piotr Jedrzejczak, Alexander N. Yatsenko, and Maciej Kurpisz. Esx1 gene as a potential candidate responsible for male infertility in nonobstructive azoospermia. Scientific Reports, October 2023. URL: http://dx.doi.org/10.1038/s41598-023-43854-9, doi:10.1038/s41598-023-43854-9. This article has 0 citations and is from a peer-reviewed journal.](https://doi.org/10.1038/s41598-023-43854-9)

[3. (Yan2000A) Yu-Ting Yan, Stacey M. Stein, Jixiang Ding, Michael M. Shen, and Cory Abate-Shen. A novel pf/pn motif inhibits nuclear localization and dna binding activity of the esx1 homeoprotein. Molecular and Cellular Biology, 20(2):661–671, January 2000. URL: http://dx.doi.org/10.1128/MCB.20.2.661-671.2000, doi:10.1128/mcb.20.2.661-671.2000. This article has 19 citations and is from a domain leading peer-reviewed journal.](https://doi.org/10.1128/MCB.20.2.661-671.2000)

[4. (Murthi2006Homeobox) P. Murthi. Homeobox gene esx1l expression is decreased in human pre-term idiopathic fetal growth restriction. Molecular Human Reproduction, 12(5):335–340, April 2006. URL: http://dx.doi.org/10.1093/molehr/gal037, doi:10.1093/molehr/gal037. This article has 22 citations and is from a peer-reviewed journal.](https://doi.org/10.1093/molehr/gal037)

[5. (Ma2021Association) Qian Ma, Ye Du, Xiaomin Luo, Jing Ye, and Yaoting Gui. Association of esx1 gene variants with non-obstructive azoospermia in chinese males. Scientific Reports, February 2021. URL: http://dx.doi.org/10.1038/s41598-021-84182-0, doi:10.1038/s41598-021-84182-0. This article has 3 citations and is from a peer-reviewed journal.](https://doi.org/10.1038/s41598-021-84182-0)